April 13, 2015 Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers April 13, 2015 Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers FDA and EMA Letters of Sup
February 6, 2015 European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development February 6, 2015 European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development Provides maj
January 15, 2015 CFAST Launches Two New CDISC Therapeutic Area Standards For Influenza and QT Studies January 15, 2015 CFAST Launches Two New CDISC Therapeutic Area StandardsFor Influenza and QT Studies Austin, TX – 15 January 2
January 12, 2015 Critical Path Institute Secures Additional Regulatory Support For Kidney Safety Biomarkers January 12, 2015 Critical Path Institute Secures Additional Regulatory Support For Kidney Safety Biomarkers EMA Letter of Support
December 8, 2014 Critical Path Institute Receives Third Grant To Accelerate Tuberculosis Diagnostics Critical Path Institute Receives Third Grant To Accelerate Tuberculosis Diagnostics Multi-Year Grant to Fund Innovative Global Dat
December 3, 2014 Conference Highlights Public Private Partnership Role in Medical Product Development December 3, 2014 | Download PDF Conference Highlights Public Private Partnership Role in Medical Product Development Global
November 19, 2014 CDISC and TransCelerate Announce Availability of New Standards for Diabetes and Cardiovascular Disease CDISC and TransCelerate Announce Availability of New Standards for Diabetes and Cardiovascular Disease Austin, TX – 19 Novemb